FindTrial
Sign In

Study on the therapeutic Management in CKD Patients under Dialysis.

Medication Management Review Program for CKD patients under Dialysis.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/03/050693
Enrollment
221
Registered
2023-03-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N189- Chronic kidney disease, unspecified

Interventions

None listed

Sponsors

MAHE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All Chronic Kidney Disease patients undergoing dialysis Chronic Kidney Disease out patient with co-morbidities Pediatric patients above 2 years having Chronic Kidney Disease Psychiatric patients having Chronic Kidney Disease

Exclusion criteria

Exclusion criteria: Patients with acute kidney injury Pregnant women with Chronic Kidney Disease Patients who have undergone recent kidney transplantation

Design outcomes

Primary

MeasureTime frame
Adherence to the Medication that is provided to the Chronic Kidney disease Patients. Timepoint: 1st day baseline characteristics,1st follow up after 1 week, 2nd follow up after 2 weeks—

Secondary

MeasureTime frame
checking for CKD progression in outpatients which may lead to inpatient hospital admissions.Timepoint: 1st day baseline characteristics,1st follow up after 1 week, 2nd follow up after 2 weeks—

Countries

India

Contacts

Public ContactMohammed Salim K T

Manipal College of Pharmaceutical Sciences, Manipal

salim.kt@manipal.edu9656798071

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026